Accessibility Menu
Bullfrog Ai logo

Bullfrog Ai(NASDAQ) BFRG

Market Cap$10.54MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2023)-88%
5 YearN/A
1 Year-56%
1 Month-18%
$0.56
-2.24%
-0.01Today
Bullfrog Ai last closing stock price
MetricPriceDate
Last closeUSD 0.572026-08-14
Bullfrog Ai stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-3.69%USD 0.592026-08-07
1 month-17.65%USD 0.692026-07-15
3 month-3.91%USD 0.592026-05-15
Year to date-35.64%USD 0.882025-12-31
1 year-55.61%USD 1.282025-08-14
3 year-84.04%USD 3.562023-08-15
Since inception-88.06%USD 4.762023-02-14

Bullfrog Ai Financials at a Glance

Market Cap

$10.54MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$298.80K

Net Income (TTM)

-$6.00M

EPS (TTM)

-$0.55

P/E Ratio

-1.03

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.56

Volume

56,430

Open

$0.58

Previous Close

$0.56

Daily Range

$0.56 - $0.58

52-Week Range

$0.43 - $2.04

Estimated Earnings Date

Nov 13, 2026

BFRG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bullfrog Ai

Bullfrog AI uses artificial intelligence to help drug companies analyze medical data. Its main platform, bfLEAP, helps researchers find patterns in complex health information. The company’s tools aim to speed up drug development and improve treatment decisions.

Products and Services

  • bfLEAP platform: AI-driven tool for analyzing clinical and laboratory data; 100% of 2025 revenue.
  • BullFrog Data Networks: Integrates and analyzes genetic, clinical, and real-world health data for research.
  • bfPREP: Cleans and standardizes medical datasets for easier analysis by researchers and companies.
  • Drug Asset Licensing: Holds rights to early-stage drug candidates from universities for cancer and liver diseases.
  • Contract AI Services: Provides data analysis services to pharmaceutical partners on a fee-for-service basis.

Growth and Expansion

  • Secured exclusive licenses from Johns Hopkins University and George Washington University in 2022 for drug candidates.
  • Launched BullFrog Data Networks and bfPREP platforms in 2025 to expand analytics offerings.
  • Formed a partnership with Eleison Pharmaceuticals in 2025 for clinical trial analytics and with Lieber Institute for Brain Development in 2023 for brain data analytics.
  • Signed joint marketing agreement with Sygnature Discovery in 2025 to promote AI platform.
  • Announced new scenario-based decision engine for drug development, planned for 2026.

What Makes Bullfrog AI Stand Out

Bullfrog AI’s proprietary platform handles messy, incomplete medical data, helping partners find new drug targets. Its exclusive university licenses give access to promising drug candidates. The company focuses on partnerships and contract services, not direct drug sales.

Five Things You Need to Know

  • Revenue was $116,670 in 2025, up from $0 in 2024.
  • All 2025 revenue came from a single collaboration with Eleison Pharmaceuticals.
  • Operating loss was $6.6 million in 2025, down 9% from 2024.
  • Cash and equivalents were $2.2 million as of December 31, 2025.
  • Company faces ongoing losses and risks Nasdaq delisting due to low equity and share price.

Bottom Line

Bullfrog AI combines artificial intelligence with drug research through partnerships and licensing. The company remains early-stage, with limited revenue and ongoing financial challenges.

AI Generated • Apr 16, 2026

Industry

Health Care Technology

Sector

Health Care

Employees

9

CEO

Vininder Singh, MBA

Website

www.bullfrogai.com

Headquarters

Gaithersburg, MD 20878, US

BFRG Financials

Key Financial Metrics (TTM)

Gross Margin

40.78%

Operating Margin

-2042.19%

Net Income Margin

-2006.87%

Return on Equity

-150.34%

Return on Capital

-308.69%

Return on Assets

-77.94%

Earnings Yield

-97.09%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$10.54MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

18.54M

Volume

56.43K

Avg. Volume

210.90K

Financials (TTM)

Gross Profit

$121.84K

Operating Income

-$6.10M

EBITDA

-$6.04M

Operating Cash Flow

-$5.50M

Capital Expenditure

$0.00

Free Cash Flow

-$5.50M

Cash & ST Invst.

$6.92M

Total Debt

$0.00

Bullfrog Ai Performance Analysis

Bullfrog Ai annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 10,000N/A
20232023-12-31USD 65,000550.0%
20242024-12-31USD 0N/A
20252025-12-31USD 116,670N/A
Bullfrog Ai sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30150.8%
Q42025-12-31-100.0%
Q12026-03-31N/A
Q22026-06-30N/A
Bullfrog Ai annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.46344.0%
20232023-12-31USD -0.8992.3%
20242024-12-31USD -0.85-3.6%
20252025-12-31USD -0.63-26.4%
Bullfrog Ai sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30N/A
Q42025-12-3113.3%
Q12026-03-317.7%
Q22026-06-3041.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$215.39K

+547.6%

Gross Profit

$106.90K

+1539.1%

Gross Margin

49.63%

N/A

Market Cap

$10.54MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.17M

N/A

Employees

9

N/A

Net Income

-$1.37M

+5.3%

EBITDA

-$1.42M

+1.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$6.92M

+179.7%

Total Debt

$0.00

-100.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-77.94%

N/A

Return on Invested Capital

-87.33%

N/A

Free Cash Flow

-$1.51M

-5.7%

Operating Cash Flow

-$1.51M

-5.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TRAWTraws Pharma, Inc.
$0.54-5.43%
IMRNImmuron Limited
$1.08-1.82%
COCPCocrystal Pharma, Inc.
$1.09-2.68%
BRTXBioRestorative Therapies, Inc.
$0.22-2.61%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.61-0.02%
SPCXSpace Exploration Technologies
$146.23+0.04%
IPSTIp Strategy
$7.39+2.36%
NVDANvidia
$225.01-0.00%

Questions About BFRG

What is the current price of Bullfrog Ai?

Bullfrog Ai is trading at $0.56 per share.

What is the 52-week range for Bullfrog Ai?

Over the past 52 weeks, Bullfrog Ai has traded between $0.43 and $2.04.

How much debt does Bullfrog Ai have?

As of the most recent reporting period, Bullfrog Ai reported total debt of $90.14K.

How much cash does Bullfrog Ai have on hand?

Bullfrog Ai reported $6.92M in cash and cash equivalents in its most recent financial results.

What is Bullfrog Ai’s dividend yield?

Bullfrog Ai does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services